ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
3 hedge funds and large institutions have $1.43M invested in ENVUE MEDICAL INC NEW in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
11% more capital invested
Capital invested by funds: $1.29M → $1.43M (+$137K)
0.43% more ownership
Funds ownership: 14.3% → 14.72% (+0.43%)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5K |
FEED Hedge Fund Activity: Q2 2020 in Review
3 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q2 2020, worth a combined $1.43M — up 11% from $1.29M a quarter earlier.
Fund positioning in FEED was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Kennedy Capital Management, adding an estimated $56K. The largest seller was UBS Group, cutting an estimated $5K.
- 3 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $1.43M of ENVUE MEDICAL INC NEW stock for Q2 2020, up 11% quarter-over-quarter.
- 0 funds opened new ENVUE MEDICAL INC NEW positions in Q2 2020 and 0 closed out.
- The largest ENVUE MEDICAL INC NEW buyer in Q2 2020 was Kennedy Capital Management, an estimated $56K added.
- The largest ENVUE MEDICAL INC NEW seller in Q2 2020 was UBS Group, an estimated $5K sold.
Based on aggregated 13F filings for Q2 2020.